Innovating to Advance Health Outcomes for Patients & Consumers
Have Questions About Participating in a COVID-19 Vaccine Clinical Trial? A Doctor Overseeing a Study Helps Answer ThemDid you like reading this story? Click the heart to show your love.
Johnson & Johnson Joins Other Companies in Signing a Landmark Communiqué on Expanded Global Access for COVID-19Did you enjoy reading this story? Click the heart.
Did you like taking this quiz? Click the heart to show your love.
At Johnson & Johnson, we believe that the next great idea can come from anywhere.
To help facilitate this research, Johnson & Johnson Innovation - JLABS, a global network of open innovation ecosystems, enables and empowers entrepreneurs and innovators to create and accelerate the delivery of life-saving, life-enhancing health and wellness solutions to patients around the world.
Johnson & Johnson’s Office of the Chief Medical Officer (OCMO) collaborates with JLABS to launch QuickFire Challenges to crowdsource innovative ideas and potential solutions from entrepreneurs and startups dedicated to solving important healthcare needs.
Advancing the Safe Use of Healthcare Products QuickFire Challenge
In 2017, the Johnson & Johnson OCMO together with JLABS awarded an innovator aiming to address a common and unexpected mistake that takes place in operating rooms: providing the incorrect dosage of medicine to children.
To address this challenge, start-up medical device maker Certa Dose made a dedicated effort to tackle that problem head on, becoming the awardee of the Advancing the Safe Use of Health Care Products QuickFire Challenge in 2017. This was the OCMO’s inaugural sponsorship of a JLABS QuickFire Challenge.
Certa Dose CEO Dr. Caleb Hernandez had a vision to significantly reduce pediatric medication dosing errors in response to scenarios in which hundreds of thousands of children are injured and thousands die each year from medical dosing errors. He and his team developed a science- and evidence-based tool to offer a simple and intuitive way to quickly and accurately administer medications to children. The result—reduced dosing errors among pediatric patients.
We are honored to have Johnson & Johnson Innovation recognize our company’s potential, and we look forward to making pediatric dosing errors a thing of the past.Share
Open Call for JLABS & OCMO QuickFire Challenge Submissions
Maternal Health QuickFire Challenge
According to the Centers for Disease Control (CDC) May 2019 Vital Signs Report, every year in the United States, approximately 50,000 mothers are severely injured and nearly 700 women die from pregnancy-related complications. Of these deaths, the CDC estimates that three in five are preventable and half the injuries could be avoided with proper care. While death and complication rates around the globe decrease, the United States faces increasing rates, making it the most dangerous place in the developed world to give birth.
The Johnson & Johnson OCMO Women’s Health team, together with JLABS, introduced the Maternal Health QuickFire Challenge in March 2020, inviting visionaries to submit ideas aiming to improve pregnancy, birth and postpartum care for women, making birth safer in the United States and potentially changing the trajectory of health for a lifetime.
Applications will be accepted through June 19, 2020 and the winner will be announced in the fall.
Check back for future QuickFire Challenges supported by the Johnson & Johnson OCMO.